Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Robert Pirker(Medical University of Vienna), Jose R. Pereira(Instituto do Câncer do Estado de São Paulo), Aleksandra Szczęsna(Centrum Leczenia Oparzeń), Joachim von Pawel(Asklepios Fachkliniken München-Gauting), Maciej Krzakowski(The Maria Sklodowska-Curie National Research Institute of Oncology), Rodryg Ramlau(Instytut Gruźlicy i Chorób Płuc), Ihor Vynnychenko, Keunchil Park(Sungkyunkwan University), Chih-Teng Yu(Taoyuan Chang Gung Memorial Hospital), Valentyn Ganul(Institute of Urology of the National Academy of Medical Sciences of Ukraine), Jae-Kyung Roh(Yonsei University), Emilio Bajetta, Kenneth J. O’Byrne(St. James's Hospital), Filippo de Marinis(Carlo Forlanini Hospital), Wilfried Eberhardt(University of Duisburg-Essen), Thomas Goddemeier(Merck (Germany)), Michael Emig(Merck (Germany)), U. Gatzemeier(LungenClinic Grosshansdorf)
The Lancet
May 1, 2009
Cited by 1,355Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis